InvestorsHub Logo

poonch1ne

02/13/21 3:01 AM

#298735 RE: couldbebetter #298727

Re #5 and #6, With success, Missling sounds like he could be another great German leader.

abew4me

02/13/21 1:23 PM

#298804 RE: couldbebetter #298727

Sounds like good advice...so I did a little research on AMRN and found that they received approval in other countries outside of the U.S. before getting FDA approval to market within the U.S.

This gave the generic companies in the U.S. an upper hand to create a substitute generic and sell it under another name. This has led to a very messy patent court battle.

I don't think AVXL has to worry about that scenario because they are getting A2-73 approved in the U.S. first for Rett...which should protect them from any patent infringement from the generics and BPs.

Does this make sense to you?

Let me know.

Abe